{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9352505",
  "DateCompleted": {
    "Year": "1997",
    "Month": "12",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "08",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0306-9877",
      "JournalIssue": {
        "Volume": "49",
        "Issue": "4",
        "PubDate": {
          "Year": "1997",
          "Month": "Oct"
        }
      },
      "Title": "Medical hypotheses",
      "ISOAbbreviation": "Med Hypotheses"
    },
    "ArticleTitle": "Zinc-induced suppression of inflammation in the respiratory tract, caused by infection with human rhinovirus and other irritants.",
    "Pagination": {
      "StartPage": "347",
      "EndPage": "357",
      "MedlinePgn": "347-57"
    },
    "Abstract": {
      "AbstractText": [
        "Free ionic zinc (Zn2+) in saliva shortens duration and severity of common cold (CC) symptoms. It is proposed that Zn2+ complexes with proteins of critical nerve endings and surface proteins of human rhinovirus (HRV) (a) interrupt nerve impulses and (b) block docking of HRV on intercellular adhesion molecule-1 (ICAM-1) on somatic cells, thereby interrupting HRV infection. Since leukocyte function associated antigen-1 (LFA-1) binds leukocytes to cells through ICAM-1, initiating inflammation, Zn2+ is expected to block LFA-1/ICAM-1 binding and thereby suppress inflammation. This could explain reduction of inflammation experienced by persons taking zinc gluconate/glycine (ZGG) lozenges for CC. Allergic rhinitis (AR) and CC share many common symptoms, and ZGG also mitigates AR symptoms. Focal irritation, increased ICAM-1 expression, and recruitment of leukocytes to epithelial foci are the common elements. Zinc ions may be an important anti-inflammatory factor because they can block docking of both HRV and LFA-1 with ICAM-1."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemistry, Hofstra University, Hempstead, NY, USA. chmsgn@vaxb.hofstra.edu"
          }
        ],
        "LastName": "Novick",
        "ForeName": "S G",
        "Initials": "SG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Godfrey",
        "ForeName": "J C",
        "Initials": "JC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pollack",
        "ForeName": "R L",
        "Initials": "RL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wilder",
        "ForeName": "H R",
        "Initials": "HR"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Med Hypotheses",
    "NlmUniqueID": "7505668",
    "ISSNLinking": "0306-9877"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Inflammatory Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Zinc Compounds"
    },
    {
      "RegistryNumber": "J41CSQ7QDS",
      "NameOfSubstance": "Zinc"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Inflammatory Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Trials as Topic"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Inflammation"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Rhinitis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rhinovirus"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "Saliva"
    },
    {
      "QualifierName": [
        "analysis",
        "therapeutic use"
      ],
      "DescriptorName": "Zinc"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Zinc Compounds"
    }
  ]
}